Chimeric Therapeutics LimitedASX: CHM

AML patient achieves Complete Response in CHM CORE-NK trial

Oct 7, 2024 at 3:06 AM UTC · Issued by Chimeric Therapeutics Limited

Chimeric Therapeutics Ltd has released a press release.

View Attachment